Collaboration Details

Print  Close

Title of Collaborative Activity:

FDA-NCI Quarterly Meeting

Description of Collaborative Activity:

This Quartely meeting to enhance communication between the National Cancer Institute (NCI) and the Food and Drug Administration (FDA), thereby expediting the development of new anti-cancer agents. General topics discussed include patient safety, clinical efficacy, and regulatory pathways to licensure, as well as an understanding of the operations of the sister agencies.

Type of Collaborative Activity:

Meeting/ Workshop

Year the Collaborative Activity Originated:


NIH Participating Institutes/Centers/Office of the Director:


HHS Agency Collaborators on this Activity: